Skip to main content
Medicine

Novel Organoid Platform and Research to Understand SARS-CoV-2 Biology and Therapeutics

By 18th January 2022No Comments

The following study was conducted by Scientists from Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, Utrecht, the Netherlands; Oncode Institute, Hubrecht Institute, Utrecht, the Netherlands. Study is published in Stem Cell Reports Journal – Cell Press Publishing as detailed below.

Stem Cell Reports Journal – Cell Press Publishing (2021)

The Organoid Platform: Promises and Challenges as Tools in the Fight against COVID-19

Many pathogenic viruses that affect man display species specificity, limiting the use of animal models. Studying viral biology and identifying potential treatments therefore benefits from the development of in vitro cell systems that closely mimic human physiology. In the current COVID-19 pandemic, rapid scientific insights are of the utmost importance to limit its impact on public health and society. Organoids are emerging as versatile tools to progress the understanding of SARS-CoV-2 biology and to aid in the quest for novel treatments.

Source:

Stem Cell Reports Journal – Cell Press Publishing

URL: https://www.cell.com/stem-cell-reports/fulltext/S2213-6711(20)30457-4

Citation:

Geurts, M.H., van der Vaart, J., Beumer, J., Clevers, H., 2021. The Organoid Platform: Promises and Challenges as Tools in the Fight against COVID-19. Stem Cell Reports 16(3), 412-418.